Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$102.07 - $123.37 $3.51 Million - $4.24 Million
-34,355 Closed
0 $0
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $9,691 - $11,818
85 Added 0.25%
34,355 $4.07 Million
Q4 2021

Jan 19, 2022

BUY
$115.53 - $141.46 $25,994 - $31,828
225 Added 0.66%
34,270 $4.82 Million
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $7,582 - $8,388
65 Added 0.19%
34,045 $4.02 Million
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $361,801 - $425,892
-3,420 Reduced 9.14%
33,980 $3.94 Million
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $16,870 - $19,875
-155 Reduced 0.41%
37,400 $4.48 Million
Q4 2020

Jan 13, 2021

BUY
$105.0 - $114.42 $26,250 - $28,605
250 Added 0.67%
37,555 $4.11 Million
Q3 2020

Oct 20, 2020

SELL
$91.64 - $111.29 $10,996 - $13,354
-120 Reduced 0.32%
37,305 $4.06 Million
Q2 2020

Aug 05, 2020

SELL
$76.57 - $98.0 $221,287 - $283,220
-2,890 Reduced 7.17%
37,425 $3.42 Million
Q1 2020

Apr 22, 2020

BUY
$62.82 - $91.86 $60,621 - $88,644
965 Added 2.45%
40,315 $3.18 Million
Q4 2019

Jan 22, 2020

BUY
$78.51 - $87.4 $50,638 - $56,373
645 Added 1.67%
39,350 $3.42 Million
Q3 2019

Oct 17, 2019

SELL
$81.84 - $88.74 $94,934 - $102,938
-1,160 Reduced 2.91%
38,705 $3.24 Million
Q2 2019

Jul 11, 2019

SELL
$72.88 - $85.0 $53,566 - $62,475
-735 Reduced 1.81%
39,865 $3.35 Million
Q1 2019

Apr 04, 2019

BUY
$66.22 - $80.06 $26,819 - $32,424
405 Added 1.01%
40,600 $3.25 Million
Q4 2018

Jan 15, 2019

SELL
$65.56 - $74.27 $36,385 - $41,219
-555 Reduced 1.36%
40,195 $2.91 Million
Q3 2018

Oct 04, 2018

BUY
$60.81 - $73.36 $2.48 Million - $2.99 Million
40,750 New
40,750 $2.99 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Benson Investment Management Company, Inc. Portfolio

Follow Benson Investment Management Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benson Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benson Investment Management Company, Inc. with notifications on news.